Your browser doesn't support javascript.
loading
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.
Mora, Jesus S; Genge, Angela; Chio, Adriano; Estol, Conrado J; Chaverri, Delia; Hernández, Maria; Marín, Saúl; Mascias, Javier; Rodriguez, Gabriel E; Povedano, Monica; Paipa, Andrés; Dominguez, Raul; Gamez, Josep; Salvado, Maria; Lunetta, Christian; Ballario, Carlos; Riva, Nilo; Mandrioli, Jessica; Moussy, Alain; Kinet, Jean-Pierre; Auclair, Christian; Dubreuil, Patrice; Arnold, Vincent; Mansfield, Colin D; Hermine, Olivier.
Afiliación
  • Mora JS; ALS Unit, Hospital San Rafael, Madrid, Spain.
  • Genge A; Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada.
  • Chio A; Department of Neuroscience, University of Turin, Turin, Italy.
  • Estol CJ; Neurological Center for Treatment and Rehabilitation, Buenos Aires, Argentina.
  • Chaverri D; Department of Neurology, ALS Unit, Hospital Carlos III, Madrid, Spain.
  • Hernández M; Department of Neurology, ALS Unit, Hospital Carlos III, Madrid, Spain.
  • Marín S; Department of Neurology, ALS Unit, Hospital Carlos III, Madrid, Spain.
  • Mascias J; Department of Neurology, ALS Unit, Hospital Carlos III, Madrid, Spain.
  • Rodriguez GE; Neurology Department, Neuron Motor Disease Clinic, Hospital JM Ramos, Buenos Aires, Argentina.
  • Povedano M; Neurology Department, Bellvitge Hospital-IDIBELL, Barcelona, Spain.
  • Paipa A; Neurology Department, Bellvitge Hospital-IDIBELL, Barcelona, Spain.
  • Dominguez R; Neurology Department, Bellvitge Hospital-IDIBELL, Barcelona, Spain.
  • Gamez J; Neurology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Autonomous University of Barcelona, Barcelona, Spain.
  • Salvado M; Neurology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Autonomous University of Barcelona, Barcelona, Spain.
  • Lunetta C; NEMO Clinical Centre, Serena Onlus Foundation, Milan, Italy.
  • Ballario C; Neurorosario, Rosario, Argentina.
  • Riva N; Department of Neurology-INSPE, San Raffaele Scientific Institute, Milan, Italy.
  • Mandrioli J; Department of Neurosciences, St. Agostino-Estense Hospital, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.
  • Moussy A; AB Science, Paris, France.
  • Kinet JP; AB Science, Paris, France.
  • Auclair C; Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Dubreuil P; AB Science, Paris, France.
  • Arnold V; Department of Biology, Université Paris Sud Université Paris-Saclay CNRS UMR 8113, Ecole Normale Supérieure de Cachan, Cachan, France.
  • Mansfield CD; AB Science, Paris, France.
  • Hermine O; INSERM, CNRS, Institut Paoli-Calmettes, CRCM, Centre de Référence des Mastocytoses, Equipe Labelisée Ligue Nationale Contre le Cancer, Aix-Marseille University, Marseille, France; and.
Article en En | MEDLINE | ID: mdl-31280619

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tiazoles / Riluzol / Esclerosis Amiotrófica Lateral Tipo de estudio: Clinical_trials Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tiazoles / Riluzol / Esclerosis Amiotrófica Lateral Tipo de estudio: Clinical_trials Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2020 Tipo del documento: Article